Functional aging in fibrotic interstitial lung disease: The impact of frailty on adverse health outcomes.

Guler, Sabina A; Kwan, Joanne M; Leung, Janice M; Khalil, Nasreen; Wilcox, Pearce G; Ryerson, Christopher J (2020). Functional aging in fibrotic interstitial lung disease: The impact of frailty on adverse health outcomes. European respiratory journal, 55(1) European Respiratory Society 10.1183/13993003.00647-2019

Preview

Text 13993003.00647-2019.full.pdf - Accepted Version Available under License Publisher holds Copyright. Download (1MB) | Preview

BACKGROUND

Accelerated biological and functional aging is common in fibrotic interstitial lung disease (ILD); however, their impact on adverse health outcomes has not been evaluated in this population.

METHODS

Patients were prospectively recruited from a specialised ILD clinic. Functional aging was determined by the frailty index (FI), and biological age by measurement of absolute telomere length (aTL) from patients' peripheral blood leukocytes. Adverse health outcomes included health-related quality of life (St George's Respiratory Questionnaire), number and length of respiratory and non-respiratory hospitalisations, medication tolerability, and time to death or lung transplantation. Multivariable models were used to determine the risks and rates of adverse health outcomes associated with the FI and aTL.

RESULTS

540 patients with fibrotic ILD, including 100 with idiopathic pulmonary fibrosis (IPF), provided 749 FI assessments, with 189 patients providing blood samples. The FI was strongly associated with quality of life, rate of hospitalisation, time to hospital discharge, and mortality, including with adjustment for age, sex, disease severity, and IPF diagnosis. Mortality prognostication was improved by the addition of the FI to commonly used clinical parameters and previously validated composite indices. Conversely, aTL was not associated with most adverse health outcomes. The effect of chronological age on outcomes was mediated primarily by the FI and to a lesser extent by aTL.

CONCLUSIONS

Functional aging is associated with adverse health outcomes in patients with fibrotic ILD, indicating the need for consideration of the individual functional age into clinical decision-making.

Interest & Impact

Downloads

218 since deposited on 11 Nov 2019
17 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item